BioCentury | Jul 25, 2016
Company News

Sun Pharma, Sun Pharmaceutical deal

...Sun Pharma Advanced Research Co. (SPARC) granted Sun Pharma U.S. rights to Elepsia XR levetiracetam, an extended-release...
...$10 million up front and is eligible for undisclosed milestone and royalty payments. FDA approved Elepsia XR...
BioCentury | Oct 2, 2006
Company News

Schwarz Pharma, UCB deal

...rheumatoid arthritis (RA) and in Phase II testing to treat psoriasis. UCB also has Keppra levetiracetam extended-release...
Items per page:
1 - 2 of 2